Clinical Trial Update: Efficacy and Safety of Rifaximin in Treating MAFLD [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial is evaluating the efficacy and safety of rifaximin for metabolic-associated fatty liver disease (MAFLD) and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic-associated Fatty Liver Disease

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Metabolic-associated Fatty Liver Disease | EARLY_Phase 1 | Status: RECRUITING